J. David Enloe Jr.
Net Worth

Last updated:

What is J. David Enloe Jr. net worth?

The estimated net worth of Mr. J. David Enloe Jr. is at least $3,318,905 as of 28 Aug 2023. He owns shares worth $2,296,785 as insider and has received compensation worth at least $1,022,120 in Recro Pharma, Inc..

What is the salary of J. David Enloe Jr.?

Mr. J. David Enloe Jr. salary is $255,530 per year as Pres, Chief Executive Officer & Director in Recro Pharma, Inc..

How old is J. David Enloe Jr.?

Mr. J. David Enloe Jr. is 61 years old, born in 1964.

What stocks does J. David Enloe Jr. currently own?

As insider, Mr. J. David Enloe Jr. owns shares in one company:

Company Title Shares Price per share Total value
Recro Pharma, Inc. (REPH) Pres, Chief Executive Officer & Director 1,098,940 $2.09 $2,296,785

What does Recro Pharma, Inc. do?

Recro Pharma, Inc., a contract development and manufacturing organization, engages in the development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecule therapeutic development in the United States and internationally. It offers its products in the form of oral solid doses, sterile injectables, oral liquids, tablets, topicals, liquid/powder filled capsules, ophthalmic droppers, liposomes, and nano/microparticles, as well as in the areas of aseptic fill/finish, lyophilization, packaging, and logistics services. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008. Recro Pharma, Inc. was incorporated in 2007 and is based in Exton, Pennsylvania.

REPH logo
REPH
Recro Pharma, Inc.
$2.09

J. David Enloe Jr. insider trading

Recro Pharma, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 125,000 $0.4 $50,000
Purchase
Common Stock 660 $1.71 $1,129
Purchase
Common Stock 625 $1.69 $1,056
Purchase
Common Stock 714 $1.41 $1,007
Purchase
Common Stock 757 $1.26 $954
Purchase
Common Stock 1,150 $0.81 $930
Purchase
Common Stock 1,562 $0.68 $1,062
Purchase
Common Stock 1,086 $0.96 $1,044
Purchase
Common Stock 625 $1.63 $1,019
Purchase
Common Stock 512 $1.96 $1,004
Purchase
Common Stock 571 $1.77 $1,011
Purchase
Common Stock 602 $1.68 $1,011
Purchase
Common Stock 617 $1.61 $993
Purchase
Common Stock 1,725 $1.68 $2,895

Recro Pharma key executives

Recro Pharma, Inc. executives and other stock owners filed with the SEC: